Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+30.28%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$116B
AUM Growth
+$12.9B
Cap. Flow
-$7.32B
Cap. Flow %
-6.32%
Top 10 Hldgs %
14.35%
Holding
3,987
New
586
Increased
1,423
Reduced
1,366
Closed
597

Top Buys

1
ZM icon
Zoom
ZM
+$1.14B
2
ABBV icon
AbbVie
ABBV
+$537M
3
TMUS icon
T-Mobile US
TMUS
+$504M
4
BIDU icon
Baidu
BIDU
+$474M
5
KR icon
Kroger
KR
+$448M

Sector Composition

1 Healthcare 23.45%
2 Technology 16.11%
3 Consumer Staples 10.59%
4 Consumer Discretionary 9.95%
5 Communication Services 9.52%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BELFA icon
3101
Bel Fuse Class A
BELFA
$1.61B
$252K ﹤0.01%
25,100
+500
+2% +$5.02K
BIOL
3102
DELISTED
Biolase, Inc.
BIOL
$252K ﹤0.01%
218
+193
+772% +$223K
BGSF icon
3103
BGSF Inc
BGSF
$72M
$251K ﹤0.01%
22,200
-93,500
-81% -$1.06M
WSO.B
3104
Watsco, Inc. Class B
WSO.B
$250K ﹤0.01%
1,400
+100
+8% +$17.9K
KODK icon
3105
Kodak
KODK
$484M
$248K ﹤0.01%
111,331
-118,169
-51% -$263K
TYME
3106
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$248K ﹤0.01%
+186,531
New +$248K
FRTA
3107
DELISTED
Forterra, Inc
FRTA
$246K ﹤0.01%
22,000
-202,073
-90% -$2.26M
MBOT icon
3108
Microbot Medical
MBOT
$189M
$245K ﹤0.01%
35,400
-79,513
-69% -$550K
GENE
3109
DELISTED
Genetic Technologies Ltd.
GENE
$242K ﹤0.01%
21,233
-11,388
-35% -$130K
REPL icon
3110
Replimune Group
REPL
$471M
$241K ﹤0.01%
9,700
-8,000
-45% -$199K
MRUS icon
3111
Merus
MRUS
$5.28B
$240K ﹤0.01%
14,900
PLXP
3112
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$240K ﹤0.01%
73,983
-417
-0.6% -$1.35K
SONM icon
3113
Sonim Technologies
SONM
$11M
$238K ﹤0.01%
2,968
+2,610
+729% +$209K
DLA
3114
DELISTED
Delta Apparel Inc.
DLA
$238K ﹤0.01%
19,600
-5,600
-22% -$68K
FFBW
3115
DELISTED
FFBW, Inc. Common Stock
FFBW
$238K ﹤0.01%
27,626
-6,347
-19% -$54.7K
JP
3116
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
$237K ﹤0.01%
156,678
+70,578
+82% +$107K
KROS icon
3117
Keros Therapeutics
KROS
$640M
$236K ﹤0.01%
+6,300
New +$236K
KREF
3118
KKR Real Estate Finance Trust
KREF
$637M
$235K ﹤0.01%
14,200
-116,900
-89% -$1.93M
EPIX icon
3119
ESSA Pharma
EPIX
$9.82M
$234K ﹤0.01%
+37,777
New +$234K
YTRA icon
3120
Yatra Online
YTRA
$91.1M
$231K ﹤0.01%
340,402
+129,502
+61% +$87.9K
MSON
3121
DELISTED
Misonix Inc
MSON
$231K ﹤0.01%
17,007
-42,448
-71% -$577K
IMTE icon
3122
Integrated Media Technology
IMTE
$3.88M
$231K ﹤0.01%
+6,249
New +$231K
HNI icon
3123
HNI Corp
HNI
$2.11B
$229K ﹤0.01%
7,500
-119,000
-94% -$3.63M
DFE icon
3124
WisdomTree Europe SmallCap Dividend Fund
DFE
$182M
$228K ﹤0.01%
4,600
-12,500
-73% -$620K
OUT icon
3125
Outfront Media
OUT
$3.13B
$227K ﹤0.01%
16,256
-2,807,358
-99% -$39.2M